ID

30476

Description

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT00442481

Lien

https://clinicaltrials.gov/show/NCT00442481

Mots-clés

Versions (1)
  1. 07/06/2018 07/06/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

7 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Major Depressive Disorder NCT00442481

Anglais

Eligibility Major Depressive Disorder NCT00442481

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients suffering from mdd, excluding a depressive episode of bipolar disorder.
Description

Major Depressive Disorder | Exclusion Depressive episode Bipolar Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C1269683
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C0349217
UMLS CUI [2,3]
C0005586
the depressive episode is not secondary to a general medical condition or substance abuse.
Description

Exclusion Criteria | Depressive episode Secondary to Medical condition General | Depressive episode Secondary to Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0349217
UMLS CUI [2,2]
C0175668
UMLS CUI [2,3]
C3843040
UMLS CUI [2,4]
C0205246
UMLS CUI [3,1]
C0349217
UMLS CUI [3,2]
C0175668
UMLS CUI [3,3]
C0038586
ages between 18-65 years old.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patients receiving other medications must be on a stable dosage for one month before entering the trial, including hypnotics.
Description

Pharmaceutical Preparations Dosage Stable | Hypnotics Dosage Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0020591
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
able to understand and sign an informed consent form.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients suffering from sleep disturbances due to a physical condition (copd, sleep apnea or essential insomnia preceding the diagnosis of depression).
Description

Sleep disturbances Due to Physical Condition | Chronic Obstructive Airway Disease | Sleep Apnea | Sleeplessness Essential

Type de données

boolean

Alias
UMLS CUI [1,1]
C0037317
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3714565
UMLS CUI [2]
C0024117
UMLS CUI [3]
C0037315
UMLS CUI [4,1]
C0917801
UMLS CUI [4,2]
C0205224
patients suffering from an unstable clinically significant medical condition (cardiovascular, endocrine, nutritional, hepatic, urinary).
Description

Medical condition Unstable | Cardiovascular Diseases | Endocrine System Diseases | Nutrition Disorders | Liver diseases | Urinary system Diseases

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0443343
UMLS CUI [2]
C0007222
UMLS CUI [3]
C0014130
UMLS CUI [4]
C3714509
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0042075
patients suffering from a malignancy or neuro-degenerative such as parkinsons’
Description

Malignant Neoplasms | Neurodegenerative Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0524851
disease
Description

Parkinson Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0030567
patients suffering from a clinically significant psychiatric psychotic disease, as judged by dsm-iv criteria, such as schizophrenia or acute psychosis.
Description

Mental disorders Psychotic | Schizophrenia | Psychotic Disorders

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0459435
UMLS CUI [2]
C0036341
UMLS CUI [3]
C0033975
patients experiencing severe withdrawal symptoms following a discontinuation of hypnotic drugs, upon entry into the baseline phase.
Description

Withdrawal Symptoms Severe | Status post Hypnotics Discontinuation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087169
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0020591
UMLS CUI [2,3]
C1444662
history of drug or alcohol dependence within the last year.
Description

Substance Dependence

Type de données

boolean

Alias
UMLS CUI [1]
C0038580
Retour au début de la page

Similar models

Eligibility Major Depressive Disorder NCT00442481

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Major Depressive Disorder | Exclusion Depressive episode Bipolar Disorder
Item
patients suffering from mdd, excluding a depressive episode of bipolar disorder.
boolean
C1269683 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C0349217 (UMLS CUI [2,2])
C0005586 (UMLS CUI [2,3])
Exclusion Criteria | Depressive episode Secondary to Medical condition General | Depressive episode Secondary to Substance Use Disorders
Item
the depressive episode is not secondary to a general medical condition or substance abuse.
boolean
C0680251 (UMLS CUI [1])
C0349217 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C3843040 (UMLS CUI [2,3])
C0205246 (UMLS CUI [2,4])
C0349217 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0038586 (UMLS CUI [3,3])
Age
Item
ages between 18-65 years old.
boolean
C0001779 (UMLS CUI [1])
Pharmaceutical Preparations Dosage Stable | Hypnotics Dosage Stable
Item
patients receiving other medications must be on a stable dosage for one month before entering the trial, including hypnotics.
boolean
C0013227 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0020591 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Informed Consent
Item
able to understand and sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Sleep disturbances Due to Physical Condition | Chronic Obstructive Airway Disease | Sleep Apnea | Sleeplessness Essential
Item
patients suffering from sleep disturbances due to a physical condition (copd, sleep apnea or essential insomnia preceding the diagnosis of depression).
boolean
C0037317 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3714565 (UMLS CUI [1,3])
C0024117 (UMLS CUI [2])
C0037315 (UMLS CUI [3])
C0917801 (UMLS CUI [4,1])
C0205224 (UMLS CUI [4,2])
Medical condition Unstable | Cardiovascular Diseases | Endocrine System Diseases | Nutrition Disorders | Liver diseases | Urinary system Diseases
Item
patients suffering from an unstable clinically significant medical condition (cardiovascular, endocrine, nutritional, hepatic, urinary).
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2])
C0014130 (UMLS CUI [3])
C3714509 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0042075 (UMLS CUI [6])
Malignant Neoplasms | Neurodegenerative Disorders
Item
patients suffering from a malignancy or neuro-degenerative such as parkinsons’
boolean
C0006826 (UMLS CUI [1])
C0524851 (UMLS CUI [2])
Parkinson Disease
Item
disease
boolean
C0030567 (UMLS CUI [1])
Mental disorders Psychotic | Schizophrenia | Psychotic Disorders
Item
patients suffering from a clinically significant psychiatric psychotic disease, as judged by dsm-iv criteria, such as schizophrenia or acute psychosis.
boolean
C0004936 (UMLS CUI [1,1])
C0459435 (UMLS CUI [1,2])
C0036341 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
Withdrawal Symptoms Severe | Status post Hypnotics Discontinuation
Item
patients experiencing severe withdrawal symptoms following a discontinuation of hypnotic drugs, upon entry into the baseline phase.
boolean
C0087169 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0020591 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
Substance Dependence
Item
history of drug or alcohol dependence within the last year.
boolean
C0038580 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial